Triple
T17918506
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Peter G. Schultz |
E447999
|
entity |
| Predicate | founded |
P104
|
FINISHED |
| Object | Ambrx |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Ambrx | Statement: [Peter G. Schultz, founded, Ambrx]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Ambrx Context triple: [Peter G. Schultz, founded, Ambrx]
-
A.
Kymab
Kymab is a biotechnology company based in Cambridge, UK, focused on developing antibody-based therapeutics using its proprietary transgenic mouse platforms.
-
B.
Amlux
Amlux is a 2002 experimental noise album by Japanese artist Merzbow, known for its dense, immersive soundscapes and prominent place in his extensive discography.
-
C.
Abraxis BioScience
Abraxis BioScience was a biopharmaceutical company best known for developing the cancer drug Abraxane and focusing on nanoparticle-based chemotherapy treatments.
-
D.
Alkermes
Alkermes is a biopharmaceutical company that develops innovative medicines for central nervous system disorders and other serious chronic diseases.
-
E.
Altabix
Altabix is a residential neighborhood in the city of Elche, Spain, known for its local sports facilities and community-focused urban environment.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Ambrx Target entity description: Ambrx is a biotechnology company specializing in engineered biologics and next-generation antibody-drug conjugates using expanded genetic code technology.
-
A.
Kymab
Kymab is a biotechnology company based in Cambridge, UK, focused on developing antibody-based therapeutics using its proprietary transgenic mouse platforms.
-
B.
Amlux
Amlux is a 2002 experimental noise album by Japanese artist Merzbow, known for its dense, immersive soundscapes and prominent place in his extensive discography.
-
C.
Abraxis BioScience
Abraxis BioScience was a biopharmaceutical company best known for developing the cancer drug Abraxane and focusing on nanoparticle-based chemotherapy treatments.
-
D.
Alkermes
Alkermes is a biopharmaceutical company that develops innovative medicines for central nervous system disorders and other serious chronic diseases.
-
E.
Altabix
Altabix is a residential neighborhood in the city of Elche, Spain, known for its local sports facilities and community-focused urban environment.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8b9f6d394819082a6d69fd1e23d2f |
completed | April 10, 2026, 8:51 a.m. |
| NER | Named-entity recognition | batch_69e4a30844548190b7a43c2f093f35d7 |
completed | April 19, 2026, 9:40 a.m. |
Created at: April 10, 2026, 10:20 a.m.